CClinicalTrials.gg
CompletedNCT06808594Updated Feb 5, 2025

The Use of Adaptive Proximal Scaphoid Implant (APSI): Long Term Follow-up

An interventional study of APSI prosthesis implant in Scaphoid Non-union Advanced Collapse (SNAC Wrist), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Completed. Per ClinicalTrials.gov, last updated 2025-02-05.

Sponsored by Azienda Ospedaliera Universitaria Integrata Verona · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 25 years 1 month after the study started (first participant enrolled Dec 1999, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Sex
All
01

Study summary

Scaphoid proximal pole fracture with avascular necrosis is a complex surgical problem. In some cases, it's possible to perform a scaphoid hemiarthroplasty with an adaptative proximal scaphoid implant (APSI), made of pyrocarbon, replacing the necrotic proximal pole. APSI allows an early mobilization of the wrist, an optimal recovery of strength and a rapid return to normal daily and work activities without limitations. This implant delays palliative and more invasive surgical treatments in patients that are generally young with high functional demands. The investigators have performed a long-term follow up (with a mean follow-up of 17 years) of the early cases of APSI implant performed, starting from 1999. Radiographic and clinical strength recovery, along with subjective outcomes, have been shown to be good, with a rapid return to daily and work activities, indicating that APSI implants are a good alternative to traditional and invasive techniques.

02

Conditions studied

  • Scaphoid Non-union Advanced Collapse (SNAC Wrist)

Browse trials for

Keywords

  • osteoarthritis
  • arthroplasty
  • Scaphoid fracture
  • Pyrocarbon
  • Bone implant
03

In context

Shock

916 studies on the registry are indexed under Shock; 176 are open to participants now.

This study's enrollment of 36 is below the median of 77 across 540 interventional studies indexed under Shock.

Browse Shock studies →

Lead sponsor

Azienda Ospedaliera Universitaria Integrata Verona is the lead sponsor of 92 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients who underwent APSI implant surgery in the period from December 1999 to December 2016, with surgery performed via dorsal or volar approach in the case of previous surgical access;
  • collection of informed consent to the processing of personal data by the Patients contacted in order to be included in the study.

Exclusion criteria

Exclusion Criteria:

  • patients for whom it was not possible to obtain informed consent to the processing of personal data.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Long term follow-up of patients treated with APSI

    Long-term clinical and radiographic outcomes in patients undergoing APSI (Adaptive Proximal Scaphoid Implant); evaluation of wrist strength and ROM (Range of Motion) on the operated side compared with the healthy side; evaluation of daily, work and sports autonomy with DASH (Disabilities of the Arm, Shoulder, and Hand) and PRWE (Patient Rated Wrist Evaluation) questionnaires and evaluating the return to normal daily, work and sports activities pre-surgery; quantification of pain at the site of surgery.

    Device: APSI prosthesis implant

Interventions

  • DeviceAPSI prosthesis implant

    The adaptative proximal scaphoid implant (APSI) is a pyrocarbon partial scaphoid prosthesis, ovoid and unfixed, which replaces the proximal pole of the scaphoid and allows adaptative mobility in the movements of the first chain and restores the geometry of the carpus, thus preventing the evolution in SNAC (Scaphoid Non-union Advanced Collapse). Pyrocarbon has good compatibility with joint cartilage and bone, a modulus of elasticity similar to bone minimizing stress shielding effects and resorption. The implant is designed with two radii of curvature: in the frontal plane, the smaller radius of curvature corresponds to the scaphoid fossa, and the larger radius of curvature is directed anteroposteriorly to the transverse plane. When it's correctly positioned, the smallest radius of the curvature is visible in the anteroposterior view, whereas it's greater in the lateral view. These two axes of the implant make it adaptable to the kinematics of the wrist.

06

What researchers measure

Primary outcomes

  1. Radiographic outcome

    X-Rays showed that all the implants were correctly positioned, without any particular or evident erosion of the surrounding bone structures. A pattern of moderate or non-severe degree of arthrosis of the wrist could generally be found. By comparing the X-rays taken at the follow-up, it was possible to detect a general slight evolution of the arthritic in the wrist compared to what was visible at the beginning of the treatment, in all the patients.

    Time frame: Through study completion, an average of 17 year

Secondary outcomes

  1. DASH (Disabilities of the Arm, Shoulder, and Hand)

    The DASH is a self-administered questionnaire of over 30 questions designed to measure function and symptoms in patients with any musculoskeletal disorder of the upper limb. MAX 100, MIN 0

    Time frame: Through study completion, an average of 17 year

  2. PRWE (Patient Rated Wrist Evaluation)

    The PRWE is a 15-item questionnaire designed to measure wrist pain and disability in activities of daily living. MAX 50, MIN 0

    Time frame: Through study completion, an average of 17 year

  3. VAS (Visual Analogue Scale)

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression, or compare pain severity between patients with similar conditions. MAX 10, MIN 0

    Time frame: Through study completion, an average of 17 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — Database of evaluated patients

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06808594
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Responsible party
Massimo Corain (Director, Head of Hand Surgery Unit, Principal Investigator, Azienda Ospedaliera Universitaria Integrata Verona) — Principal investigator
First posted
Feb 5, 2025
Start date
Dec 1, 1999
Primary completion
Dec 31, 2016
Completion
Dec 31, 2016
Last update
Feb 5, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion